US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 3.4800
  • +0.0100+0.29%
Close Dec 13 16:00 ET
  • 3.6000
  • +0.1200+3.45%
Post 20:01 ET
235.20MMarket Cap-2.34P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
133.29%3.37M
-10.28%-8.9M
242.43%13.85M
-506.52%-36.91M
-211.59%-9.01M
-610.97%-10.11M
-8.07M
-9.72M
-114.52%-6.09M
-158.59%-2.89M
Net income from continuing operations
-46.02%-15.12M
-5.38%-11.7M
-3,211.05%-12.28M
-534.06%-46.51M
-1,087.44%-24.68M
-668.82%-10.36M
---11.11M
---371K
-116.56%-7.34M
-95.85%-2.08M
Operating gains losses
225.00%39K
--63K
-90.91%2K
-87.21%39K
--5K
--12K
--0
--22K
2,950.00%305K
----
Depreciation and amortization
158.30%669K
132.65%570K
92.22%346K
585.51%946K
303.08%262K
304.69%259K
--245K
--180K
-7.38%138K
54.76%65K
Deferred tax
--0
--0
--0
---2.65M
--7.85M
--0
--0
---10.5M
----
----
Other non cash items
-850.00%-510K
25.00%-9K
-1,440.00%-268K
2,414.52%4.31M
19,122.73%4.23M
277.78%68K
---12K
--20K
-358.33%-186K
4.76%22K
Change In working capital
3,105.88%16.35M
15.26%1.5M
5,845.70%25.4M
617.50%2.3M
287.67%1.98M
-73.25%-544K
--1.3M
---442K
577.61%320K
-328.46%-1.05M
-Change in receivables
78.48%-133K
241.43%857K
16,700.00%166K
-273.88%-426K
-110.90%-58K
-25.35%-618K
--251K
---1K
690.32%245K
8,766.67%532K
-Change in inventory
--0
-200.00%-16K
-78.91%27K
572.37%359K
105.09%102K
34.52%113K
--16K
--128K
72.26%-76K
-1,406.77%-2M
-Change in prepaid assets
-293.00%-882K
115.84%61K
-156.67%-154K
-30.52%-325K
-400.89%-337K
3,908.33%457K
---385K
---60K
-344.64%-249K
11,100.00%112K
-Change in payables and accrued expense
3,601.41%17.37M
-57.74%601K
-419.25%-2.64M
572.00%2.69M
642.16%2.27M
-563.55%-496K
--1.42M
---509K
72.41%400K
355.00%306K
-Change in other working capital
--0
--0
--28M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
133.29%3.37M
-10.28%-8.9M
242.43%13.85M
-506.52%-36.91M
-211.59%-9.01M
-610.97%-10.11M
---8.07M
---9.72M
-114.52%-6.09M
-158.59%-2.89M
Investing cash flow
Cash flow from continuing investing activities
-13,000.00%-29.74M
-475.04%-3.3M
-287.23%-47.3M
184.51%24.37M
27.64%-89K
-773.08%-227K
-573K
25.26M
-6,933.90%-28.84M
10.87%-123K
Net PPE purchase and sale
-12,989.43%-29.71M
-82.88%-1.02M
-4,413.43%-9.07M
-609.93%-1.07M
15.24%-89K
-773.08%-227K
---555K
---201K
60.26%-151K
8.70%-105K
Net business purchase and sale
--0
--0
--0
--2.7M
--0
--0
--0
--2.7M
----
----
Net investment purchase and sale
--0
---2.28M
-267.92%-38.23M
200.33%22.76M
--0
--0
--0
--22.76M
---22.69M
----
Net other investing changes
----
----
----
99.70%-18K
--0
--0
----
----
-19,900.00%-6M
----
Cash from discontinued investing activities
Investing cash flow
-13,000.00%-29.74M
-475.04%-3.3M
-287.23%-47.3M
184.51%24.37M
27.64%-89K
-773.08%-227K
---573K
--25.26M
-6,933.90%-28.84M
10.87%-123K
Financing cash flow
Cash flow from continuing financing activities
62,700.00%628K
23,744.53%122.08M
208,010.00%166.33M
2,703.57%785K
352K
1K
512K
-80K
-99.96%28K
0
Net issuance payments of debt
23.81%-16K
60.00%-8K
20.00%-12K
---68K
---12K
---21K
---20K
---15K
----
----
Net common stock issuance
---123K
--235.04M
--53.14M
--364K
--364K
--0
--0
--0
--0
--0
Cash dividends paid
----
----
----
----
----
----
----
----
--0
--0
Proceeds from stock option exercised by employees
3,386.36%767K
-1,994.74%-10.08M
--10.33M
1,878.57%554K
--0
--22K
--532K
--0
-94.76%28K
--0
Net other financing activities
----
----
158,353.85%102.87M
---65K
--0
--0
--0
---65K
----
----
Cash from discontinued financing activities
Financing cash flow
62,700.00%628K
23,744.53%122.08M
208,010.00%166.33M
2,703.57%785K
--352K
--1K
--512K
---80K
-99.96%28K
--0
Net cash flow
Beginning cash position
784.83%252.19M
288.43%142.3M
-55.51%9.42M
-62.24%21.18M
-69.26%18.17M
-52.92%28.5M
--36.63M
--21.18M
2,079.25%56.07M
-9.13%59.09M
Current changes in cash
-149.06%-25.74M
1,451.13%109.89M
759.56%132.88M
66.32%-11.76M
-190.15%-8.75M
-613.81%-10.34M
---8.13M
--15.46M
-156.80%-34.9M
-197.53%-3.01M
End cash Position
1,146.59%226.44M
784.83%252.19M
288.43%142.3M
-55.51%9.42M
-83.20%9.42M
-69.26%18.17M
--28.5M
--36.63M
-66.92%21.18M
-12.40%56.07M
Free cash flow
-154.88%-26.35M
-14.95%-9.92M
148.13%4.78M
-509.03%-37.99M
-203.64%-9.1M
-613.88%-10.34M
---8.63M
---9.92M
-93.82%-6.24M
-142.98%-3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 133.29%3.37M-10.28%-8.9M242.43%13.85M-506.52%-36.91M-211.59%-9.01M-610.97%-10.11M-8.07M-9.72M-114.52%-6.09M-158.59%-2.89M
Net income from continuing operations -46.02%-15.12M-5.38%-11.7M-3,211.05%-12.28M-534.06%-46.51M-1,087.44%-24.68M-668.82%-10.36M---11.11M---371K-116.56%-7.34M-95.85%-2.08M
Operating gains losses 225.00%39K--63K-90.91%2K-87.21%39K--5K--12K--0--22K2,950.00%305K----
Depreciation and amortization 158.30%669K132.65%570K92.22%346K585.51%946K303.08%262K304.69%259K--245K--180K-7.38%138K54.76%65K
Deferred tax --0--0--0---2.65M--7.85M--0--0---10.5M--------
Other non cash items -850.00%-510K25.00%-9K-1,440.00%-268K2,414.52%4.31M19,122.73%4.23M277.78%68K---12K--20K-358.33%-186K4.76%22K
Change In working capital 3,105.88%16.35M15.26%1.5M5,845.70%25.4M617.50%2.3M287.67%1.98M-73.25%-544K--1.3M---442K577.61%320K-328.46%-1.05M
-Change in receivables 78.48%-133K241.43%857K16,700.00%166K-273.88%-426K-110.90%-58K-25.35%-618K--251K---1K690.32%245K8,766.67%532K
-Change in inventory --0-200.00%-16K-78.91%27K572.37%359K105.09%102K34.52%113K--16K--128K72.26%-76K-1,406.77%-2M
-Change in prepaid assets -293.00%-882K115.84%61K-156.67%-154K-30.52%-325K-400.89%-337K3,908.33%457K---385K---60K-344.64%-249K11,100.00%112K
-Change in payables and accrued expense 3,601.41%17.37M-57.74%601K-419.25%-2.64M572.00%2.69M642.16%2.27M-563.55%-496K--1.42M---509K72.41%400K355.00%306K
-Change in other working capital --0--0--28M----------------------------
Cash from discontinued investing activities
Operating cash flow 133.29%3.37M-10.28%-8.9M242.43%13.85M-506.52%-36.91M-211.59%-9.01M-610.97%-10.11M---8.07M---9.72M-114.52%-6.09M-158.59%-2.89M
Investing cash flow
Cash flow from continuing investing activities -13,000.00%-29.74M-475.04%-3.3M-287.23%-47.3M184.51%24.37M27.64%-89K-773.08%-227K-573K25.26M-6,933.90%-28.84M10.87%-123K
Net PPE purchase and sale -12,989.43%-29.71M-82.88%-1.02M-4,413.43%-9.07M-609.93%-1.07M15.24%-89K-773.08%-227K---555K---201K60.26%-151K8.70%-105K
Net business purchase and sale --0--0--0--2.7M--0--0--0--2.7M--------
Net investment purchase and sale --0---2.28M-267.92%-38.23M200.33%22.76M--0--0--0--22.76M---22.69M----
Net other investing changes ------------99.70%-18K--0--0---------19,900.00%-6M----
Cash from discontinued investing activities
Investing cash flow -13,000.00%-29.74M-475.04%-3.3M-287.23%-47.3M184.51%24.37M27.64%-89K-773.08%-227K---573K--25.26M-6,933.90%-28.84M10.87%-123K
Financing cash flow
Cash flow from continuing financing activities 62,700.00%628K23,744.53%122.08M208,010.00%166.33M2,703.57%785K352K1K512K-80K-99.96%28K0
Net issuance payments of debt 23.81%-16K60.00%-8K20.00%-12K---68K---12K---21K---20K---15K--------
Net common stock issuance ---123K--235.04M--53.14M--364K--364K--0--0--0--0--0
Cash dividends paid ----------------------------------0--0
Proceeds from stock option exercised by employees 3,386.36%767K-1,994.74%-10.08M--10.33M1,878.57%554K--0--22K--532K--0-94.76%28K--0
Net other financing activities --------158,353.85%102.87M---65K--0--0--0---65K--------
Cash from discontinued financing activities
Financing cash flow 62,700.00%628K23,744.53%122.08M208,010.00%166.33M2,703.57%785K--352K--1K--512K---80K-99.96%28K--0
Net cash flow
Beginning cash position 784.83%252.19M288.43%142.3M-55.51%9.42M-62.24%21.18M-69.26%18.17M-52.92%28.5M--36.63M--21.18M2,079.25%56.07M-9.13%59.09M
Current changes in cash -149.06%-25.74M1,451.13%109.89M759.56%132.88M66.32%-11.76M-190.15%-8.75M-613.81%-10.34M---8.13M--15.46M-156.80%-34.9M-197.53%-3.01M
End cash Position 1,146.59%226.44M784.83%252.19M288.43%142.3M-55.51%9.42M-83.20%9.42M-69.26%18.17M--28.5M--36.63M-66.92%21.18M-12.40%56.07M
Free cash flow -154.88%-26.35M-14.95%-9.92M148.13%4.78M-509.03%-37.99M-203.64%-9.1M-613.88%-10.34M---8.63M---9.92M-93.82%-6.24M-142.98%-3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List